8-K current report · filed Jun 3, 2026

Viridian Therapeutics, Inc.\DE (VRDN) 8-K Current Report: June 3, 2026

Short answer

Viridian Therapeutics, Inc.\DE (VRDN) filed an 8-K current report with the SEC on June 3, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders). All two Class II nominees elected through 2029, with Jennifer Moses receiving 86,378,842 votes for.

Viridian Therapeutics, Inc.\DE 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.07 · Submission of Matters to a Vote of Security Holders

  • All two Class II nominees elected through 2029, with Jennifer Moses receiving 86,378,842 votes for
  • KPMG ratified as independent auditor for fiscal 2026, with 92,866,008 votes for
  • Executive compensation approved advisory basis, with 83,512,086 votes for
  • Shareholders favored annual say-on-pay votes with 86,084,347 votes; board adopted yearly frequency

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Viridian Therapeutics, Inc.\DE 8-K filings

Get the next VRDN 8-K as it lands

Follow VRDN for push alerts, or ask the research agent what this filing means.